Legal, Legislative Quest To Expand Off-Label Part D Coverage Continues
Executive Summary
The Medicare Rights Center is continuing a lawsuit seeking to expand coverage for off-label indications under the Medicare Part D prescription drug benefit after helping a beneficiary gain coverage of a drug to treat ovarian cancer